← All organizations

Beijing Kawin Technology Share-Holding Co., Ltd.

For profitWebsite ↗

Also known as: Beijing Kawin Technology Share-Holding Co., Ltd. | KawinGreen Biotech Co., Ltd. | Kawin Technology Share-holding Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 28, 2021

Timeline

1990s

Jun 1, 1999
Beijing Kawin Technology Share-Holding Co., Ltd.— Founded

Drugs by trial phase (8 distinct, 8 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

pirfenidone

Indications

Studied for

Recent trials (14)

NCT06544551Lead sponsorPhase 3Dec 28, 2021
NCT03995485Lead sponsorPhase 3Jun 7, 2017
NCT03995485CollaboratorPhase 3Jun 7, 2017
NCT03416491Lead sponsorPhase 2Feb 15, 2017
NCT03416491CollaboratorPhase 2Feb 15, 2017
NCT03453346CollaboratorN/AAug 5, 2016
NCT03453346Lead sponsorN/AAug 5, 2016
NCT02360592CollaboratorPhase 4Apr 1, 2014
NCT01903278Reponsible party - principal investigatorPhase 3Jun 1, 2013
NCT01903278Lead sponsorPhase 3Jun 1, 2013
NCT01908335Reponsible party - principal investigatorPhase 2Oct 1, 2012
NCT01908335Lead sponsorPhase 2Oct 1, 2012
NCT01504334Lead sponsorPhase 2Jan 1, 2012
NCT01504334Reponsible party - principal investigatorPhase 2Jan 1, 2012

Details

Founded: Beijing, CN Jun 1, 1999
Last known activity: Dec 28, 2021